196 related articles for article (PubMed ID: 24519316)
1. Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach.
Mahmood I
Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):53-9. PubMed ID: 24519316
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
Mahmood I; Ahmad T; Mansoor N; Sharib SM
J Clin Pharmacol; 2017 Apr; 57(4):476-483. PubMed ID: 27704554
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.
Mahmood I
J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
Mahmood I
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
[TBL] [Abstract][Full Text] [Related]
5. Prediction of drug clearance in children: an evaluation of the predictive performance of several models.
Mahmood I; Staschen CM; Goteti K
AAPS J; 2014 Nov; 16(6):1334-43. PubMed ID: 25274608
[TBL] [Abstract][Full Text] [Related]
6. Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.
Mahmood I
Ther Drug Monit; 2007 Jun; 29(3):271-8. PubMed ID: 17529882
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.
Mahmood I; Tegenge MA
Clin Pharmacokinet; 2017 Dec; 56(12):1567-1576. PubMed ID: 28405936
[TBL] [Abstract][Full Text] [Related]
8. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.
Edginton AN; Shah B; Sevestre M; Momper JD
Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537
[TBL] [Abstract][Full Text] [Related]
9. Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model.
Peeters MY; Allegaert K; Blussé van Oud-Alblas HJ; Cella M; Tibboel D; Danhof M; Knibbe CA
Clin Pharmacokinet; 2010 Apr; 49(4):269-75. PubMed ID: 20214410
[TBL] [Abstract][Full Text] [Related]
10. Allometry Is a Reasonable Choice in Pediatric Drug Development.
Liu T; Ghafoori P; Gobburu JV
J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629
[TBL] [Abstract][Full Text] [Related]
11. Prediction of drug clearance in children.
Foissac F; Bouazza N; Valade E; De Sousa Mendes M; Fauchet F; Benaboud S; Hirt D; Tréluyer JM; Urien S
J Clin Pharmacol; 2015 Jul; 55(7):739-47. PubMed ID: 25721251
[TBL] [Abstract][Full Text] [Related]
12. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.
Soars MG; Burchell B; Riley RJ
J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of sigmoidal maturation and allometric models: prediction of propofol clearance in neonates and infants.
Mahmood I
Am J Ther; 2013 Jan; 20(1):21-8. PubMed ID: 23299229
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I
Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.
Mahmood I; Cheng A; Brauer E; Humeniuk R
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):767-775. PubMed ID: 26547922
[TBL] [Abstract][Full Text] [Related]
16. Allometric extrapolation of factors VII, VIII and IX clearance in children from adults.
Mahmood I
J Thromb Haemost; 2012 Aug; 10(8):1609-13. PubMed ID: 22612736
[TBL] [Abstract][Full Text] [Related]
17. Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults.
Tegenge MA; Mahmood I
Ther Drug Monit; 2018 Oct; 40(5):635-641. PubMed ID: 30086085
[TBL] [Abstract][Full Text] [Related]
18. Predicting the "First dose in children" of CYP3A-metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7-CYP3A4 switch at young ages.
Strougo A; Yassen A; Monnereau C; Danhof M; Freijer J
J Clin Pharmacol; 2014 Sep; 54(9):1006-15. PubMed ID: 24676942
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.
Mahmood I; Tegenge MA
J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?
Mahmood I
Br J Clin Pharmacol; 2011 Jan; 71(1):88-94. PubMed ID: 21143504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
